Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer
出版年份 2022 全文链接
标题
Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer
作者
关键词
-
出版物
Cancers
Volume 14, Issue 7, Pages 1801
出版商
MDPI AG
发表日期
2022-04-02
DOI
10.3390/cancers14071801
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Expression and Prognostic Significance of CD47–SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer
- (2021) Akane Sugimura-Nagata et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical significance of signal regulatory protein alpha (SIRPα) expression in esophageal squamous cell carcinoma
- (2021) Naomichi Koga et al. CANCER SCIENCE
- Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: correlation with regulatory FOXP3+T-cell tumour stroma infiltration
- (2020) Alexandra Giatromanolaki et al. BRITISH JOURNAL OF CANCER
- Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer
- (2020) Oscar Arrieta et al. Cancer Medicine
- Combination of CD47 and SIRPα constituting the "don't eat me signal" is a prognostic factor in diffuse large B‐cell lymphoma
- (2020) Ryo Kazama et al. CANCER SCIENCE
- Just eat it: A review of CD47 and SIRP-α antagonism
- (2020) Bryan Oronsky et al. SEMINARS IN ONCOLOGY
- Clinicopathological analysis of immunohistochemical expression of CD47 and SIRPα in adult T‐cell leukemia/lymphoma
- (2020) Eriko Yanagida et al. HEMATOLOGICAL ONCOLOGY
- Clinicopathological significance of CD47 expression in hepatocellular carcinoma
- (2020) Hyunsung Kim et al. JOURNAL OF CLINICAL PATHOLOGY
- Cancer immunotherapy comes of age and looks for maturity
- (2020) Amanda Finck et al. Nature Communications
- Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer
- (2020) Yan Xu et al. ESMO Open
- Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
- (2019) Jian‐Hua Wang et al. Cancer Medicine
- First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
- (2019) Branimir I. Sikic et al. JOURNAL OF CLINICAL ONCOLOGY
- Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis
- (2019) Alexandra Giatromanolaki et al. MEDICAL ONCOLOGY
- High expression of CD47 in triple negative breast cancer is associated with epithelial‑mesenchymal transition and poor prognosis
- (2019) Jingping Yuan et al. Oncology Letters
- PD-L1 and CD47 co-expression in pulmonary sarcomatoid carcinoma: a predictor of poor prognosis and potential targets of future combined immunotherapy
- (2019) Zhenlin Yang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint
- (2019) Erik Voets et al. Journal for ImmunoTherapy of Cancer
- CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+/Foxp3+ T cells
- (2018) Hiroyuki Abe et al. VIRCHOWS ARCHIV
- Significance of CD47 expression in gastric cancer
- (2017) Tomoya Sudo et al. Oncology Letters
- The CD47-SIRP signalling system: its physiological roles and therapeutic application
- (2014) Y. Murata et al. JOURNAL OF BIOCHEMISTRY
- Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
- (2013) D. Tseng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started